Iterum Therapeutics' IPO

Iterum Therapeutics raised a round of funding on May 25, 2018. Investors include Public.

Iterum Therapeutics is an Ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. These products are aimed at combating the global crisis of multi-d…

Articles about Iterum Therapeutics' IPO: